How Side Effects of Avonex Are Affected by Gradually Increasing to Full Dose vs Starting at Full Dose

Clinical trial NCT00574041 · TERMINATED

Trial details

NCT number: NCT00574041
Sponsor: Biogen
Status: TERMINATED
Phase: Phase 4
Study type: INTERVENTIONAL

Relapsing Remitting Multiple Sclerosis

Start date: 2007-06-01
Primary completion: 2008-02-01
Enrollment: 19

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.